trending Market Intelligence /marketintelligence/en/news-insights/trending/snydvisqsgsl9fvueokmgq2 content esgSubNav
In This List

Zai Lab appoints board member

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Zai Lab appoints board member

China-based biopharmaceutical company Zai Lab Ltd, which focuses on developing medicines for cancer, autoimmune and infectious diseases, appointed Kai-Xian Chen to its board.

Chen replaces Marietta Wu on the board. He has over 55 years of academic and administrative experience and has also served as a member of the National Committee of Chinese People's Political Consultative Conference from 2007 to 2017.